Samfenet

trastuzumab biosimilar

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Samfenet, covering 2020-01-02 to 2020-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid Tumor [Phase 2]

See pricing